The effect of semaphorin 3A in the process of apoptosis in oxygen induced retinopathy in rats

Chinese Journal of Ophthalmology

Volumn 50, Issue 6, 2014, Pages 440-447

  Hua, Ning ^a   Liu, Hongwei ^a   Qian, Xuehan ^a   Dong, Lijie ^a   Wu, Jingjing ^a   Li, Xiaorong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Disease models, animal; Retinopathy of prematurity; Semaphorin 3A

Indexed keywords

CASPASE 3; OXYGEN; SEMAPHORIN 3A;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CHEMICALLY INDUCED; DISEASE MODEL; MALE; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; RAT; RETINA; RETINA DEGENERATION; RETINA DISEASE; RETINA GANGLION CELL;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CASPASE 3; DISEASE MODELS, ANIMAL; MALE; OXYGEN; RANDOM ALLOCATION; RATS; RETINA; RETINAL DEGENERATION; RETINAL DISEASES; RETINAL GANGLION CELLS; SEMAPHORIN-3A;

EID: 84904733035     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0412-4081.2014.06.008     Document Type: Article

References (26)

1. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control [J]. Early Hum Dev, 2008, 84:77-82.
2. Zhu J F, Zou H D, He X G, et al. Cross-sectional investigation of visual impairing diseases in Shanghai blind children school [J]. Chin Med J(Engl), 2012, 125:3654-3659.
3. Mintz-Hittner H A, Kennedy K A, Chuang A Z, et al. Efficacy of intravitreal bevacizumab for stage 3 + retinopathy of prematurity [J]. N Engl J Med, 2011, 364:603-615.
4. Narayanan S P, Suwanpradid J, Saul A, et al. Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity [J]. PLoS One, 2011, 6: e22460.
5. Fulton A B, Akula J D, Mocko J A, et al. Retinal degenerative and hypoxic ischemic disease [J]. Doc Ophthalmol, 2009, 118:55-61.
6. Shelly M, Cancedda L, Lim B K, et al. Semaphorin3A regulates neuronal polarization by suppressing axon formation and promoting dendrite growth [J]. Neuron, 2011, 71:433-446.
7. Ko J A, Mizuno Y, Shibasaki M, et al. Differential expression of semaphorin 3 A and its receptors during mouse retinal development [J]. Cell Biochem Funct, 2012, 30:563-568.
8. Eixarch H, Gutiérrez-Franco A, Montalban X, et al. Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis [J]. Trends Mol Med, 2013, 19:157-164.
9. Klebanov O, Nitzan A, Raz D, et al. Upregulation of Semaphorin 3A and the associated biochemical and cellular events in a rat model of retinal detachment [J] . Graefes Arch Clin Exp Ophthalmol, 2009, 247:73-86.
10. Akula J D, Mocko J A, Benador I Y, et al. The neurovascular relation in oxygen- induced retinopathy [J]. Mol Vis, 2008, 14: 2499-2508.
11. Fulton A B, Akula J D, Mocko J A, et al. Retinal degenerative and hypoxic ischemic disease [J]. Doc Ophthalmol, 2009, 118:55-61.
12. Wellard J, Lee D, Valter K, et al. Photoreceptors in the rat retina are specifically vulnerable to both hypoxia and hyperoxia [J]. Vis Neurosci, 2005, 22:501-507.
13. Barnaby A M, Hansen R M, Moskowitz A, et al. Development of scotopic visual thresholds in retinopathy of prematurity [J]. Invest Ophthalmol Vis Sci, 2007, 48:4854-4860.
14. Hammer D X, Iftimia N V, Ferguson R D, et al. Foveal fine structure in retinopathy of prematurity: an adaptive optics Fourier domain optical coherence tomography study [J]. Invest Ophthalmol Vis Sci, 2008, 49:2061-2070.
15. Yang C, Lafleur J, Mwaikambo B R, et al. The role of lysophosphatidic acid receptor (LPA1) in the oxygen-induced retinal ganglion cell degeneration [J]. Invest Ophthalmol Vis Sci, 2009, 50:1290-1298.
16. De Winter F, Holtmaat A J, Verhaagen J. Neuropilin and class 3 semaphorins in nervous system regeneration [J]. Adv Exp Med Biol, 2002, 15:115-139.
17. Smith R A, Walker T, Xie X, et al. Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells [J]. Brain Res Mol Brain Res, 2003, 116:70-79.
18. Moretti S, Procopio A, Lazzarini R, et al. Semaphorin3A signaling controls Fas (CD95) -mediated apoptosis by promoting Fas translocation into lipid rafts [J]. Blood, 2008, 111:2290-2299.
19. Ben-Zvi A, Manor O, Schachner M, et al. The Semaphorin receptor PlexinA3 mediates neuronal apoptosis during dorsal root ganglia development [J]. J Neurosci, 2008, 28:12427-12432.
20. Shirvan A, Kimron M, Holdengreber V, et al. Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy [J]. J Biol Chem, 2002, 277:49799-49807.
21. Rivera J C, Sitaras N, Noueihed B, et al. Microglia and interleukin-1β in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A [J]. Arterioscler Thromb Vasc Biol, 2013, 33:1881-1891.
22. Cerani A, Tetreault N, Menard C, et al. Neuron-Derived Semaphorin 3A Is an Early Inducer of Vascular Permeability in Diabetic Retinopathy via Neuropilin-1 [J]. Cell Metab, 2013, 18: 505-518.
23. Pekcec A, Yigitkanli K, Jung J E, et al. Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling [J]. FASEB J, 2013, 27:437-445.
24. Yu W, Bai Y, Han N, et al. Inhibition of pathological retinal neovascularization by semaphorin 3A [J]. Mol Vis, 2013, 19: 1397-1405.
25. Tillo M, Ruhrberg C, Mackenzie F. Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity [J]. Cell Adh Migr, 2012, 6:541-546.
26. Katusic A, Juric-Lekic G, Jovanov-Milosević N, et al. Development of the fetal neural retina in vitro and in ectopic transplants in vivo [J]. Coll Antropol, 2008, 32:201-207.